Investing in Europe’s leading provider of AI-enabled chronic care
Pictured: Oviva’s co-founders Kai Eberhardt (CEO) and Manuel Baumann (CTO).
More than 200 million adults live with obesity and weight-related chronic conditions in Europe. Healthcare systems are strained by significant clinician shortages and a lack of access to in-person care. Oviva addresses this by offering an evidence-based, scalable, digital solution for weight-related and chronic conditions.
Oviva is the European leader in reimbursed weight-related digital care and has supported more than one million patients to date. Over the past two years, the company has tripled new patient intake, while achieving cash-flow profitability in 2025.
Kinnevik led the USD 220m Series D round with a USD 100m investment, making Kinnevik Oviva’s largest shareholder. Read more in our press release
A conversation with Kai Eberhardt
Kinnevik’s Senior Investment Director Christian Scherrer sat down with Oviva’s co-founder and CEO Kai Eberhardt to talk about what inspired him to found the company, the uniqueness of Oviva’s approach and the company’s vision for transforming chronic care in Europe.
